Published in Antimicrob Agents Chemother on February 01, 1980
Comparative activities of 13 beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 4.13
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob Agents Chemother (1981) 2.96
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1981) 2.71
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency. Antimicrob Agents Chemother (1981) 1.66
Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother (1981) 1.63
In vitro activity of cefoperazone against nonfermenters and Aeromonas hydrophila. Antimicrob Agents Chemother (1980) 1.61
Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects. Antimicrob Agents Chemother (1981) 1.51
Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria. Antimicrob Agents Chemother (1984) 1.43
Comparative in vitro activity of ceftriaxone against anaerobic bacteria. Antimicrob Agents Chemother (1982) 1.37
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin. Antimicrob Agents Chemother (1983) 1.17
Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections. Antimicrob Agents Chemother (1982) 1.12
Moxalactam pharmacokinetics during hemodialysis. Antimicrob Agents Chemother (1981) 1.02
Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Antimicrob Agents Chemother (1981) 0.99
In vitro activity of cefbuperazone against Bacteroides spp. Antimicrob Agents Chemother (1985) 0.85
Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis group. Antimicrob Agents Chemother (1981) 0.83
Moxalactam pharmacokinetics in children. Antimicrob Agents Chemother (1982) 0.80
Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds. Antimicrob Agents Chemother (1983) 0.75
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1979) 10.60
Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother (1976) 9.53
Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1976) 9.38
Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob Agents Chemother (1978) 5.81
Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. J Antimicrob Chemother (1978) 4.83
Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates. Antimicrob Agents Chemother (1977) 2.04
Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother (1978) 1.72
Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media. J Antimicrob Chemother (1978) 1.32
In vitro activity of cefaclor against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1978) 1.19
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens. Am J Clin Pathol (1970) 8.90
Differential distribution of dynamin isoforms in mammalian cells. Mol Biol Cell (1998) 3.42
Agrobacterium rhizogenes-transformed roots of Medicago truncatula for the study of nitrogen-fixing and endomycorrhizal symbiotic associations. Mol Plant Microbe Interact (2001) 3.25
Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics (1987) 2.74
Activities of new quinoline derivatives against genital pathogens. Antimicrob Agents Chemother (1985) 2.51
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation (1997) 2.17
Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med (1993) 2.16
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol (2000) 2.13
Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol (2001) 2.06
Congenital and acquired thrombotic risk factors in women using oral contraceptives: clinical aspects. Clin Appl Thromb Hemost (2000) 1.99
[Clinical microbiology: a specialty in crisis?]. Enferm Infecc Microbiol Clin (1998) 1.98
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria. Antimicrob Agents Chemother (1984) 1.77
Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1989) 1.69
Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun (2000) 1.67
CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis (2001) 1.62
How not to be seen: the contribution of similarity and selective ignoring to sustained inattentional blindness. Psychol Sci (2001) 1.60
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol (2005) 1.60
Balloon-expandable intracoronary stents in the adult dog. Circulation (1987) 1.56
Low level of circulating activated protein C is a risk factor for venous thromboembolism. Thromb Haemost (2001) 1.54
Modified test for activated protein C resistance. Lancet (1994) 1.53
Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells. Antimicrob Agents Chemother (1990) 1.51
Randomized trial of partial vs. stepwise caries removal: 3-year follow-up. J Dent Res (2012) 1.51
Analysis of charges and complications of permanent pacemaker implantation in the cardiac catheterization laboratory versus the operating room. Pacing Clin Electrophysiol (1999) 1.49
Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. Hum Reprod (2000) 1.47
Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. J Infect (2012) 1.46
HIV/AIDS practice patterns, knowledge, and educational needs among Hispanic clinicians in Texas, USA, and Nuevo Leon, Mexico. Rev Panam Salud Publica (1998) 1.46
Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples. J Urol (1998) 1.46
Genotypic identification of an undescribed spotted fever group rickettsia in Ixodes ricinus from southwestern Spain. Am J Trop Med Hyg (1998) 1.43
[Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime]. Enferm Infecc Microbiol Clin (1997) 1.39
[Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model]. Encephale (2008) 1.39
[Lactic acidosis in diabetic patients associated with buformin]. Rev Med Chil (1989) 1.38
Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells. Antimicrob Agents Chemother (1992) 1.37
Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev (2001) 1.33
Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Antimicrob Agents Chemother (2000) 1.32
Cefoxitin sodium activity against anaerobes: effect of the inoculum size, pH variation and different culture media. J Antimicrob Chemother (1978) 1.32
Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis (2002) 1.31
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J (2007) 1.28
Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin Microbiol Infect (2007) 1.28
Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology (1986) 1.27
Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob Agents Chemother (1999) 1.27
Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuber Lung Dis (1999) 1.25
Bimodal atomic force microscopy imaging of isolated antibodies in air and liquids. Nanotechnology (2008) 1.25
Comparative clinical efficacy of two different single-dose ciprofloxacin treatments for uncomplicated gonorrhea. Sex Transm Dis (1986) 1.21
Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer (2005) 1.20
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother (1999) 1.20
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis (1997) 1.16
Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cells. Antimicrob Agents Chemother (1997) 1.15
Comparative in vitro activities of new quinolones against coryneform bacteria. Antimicrob Agents Chemother (1994) 1.15
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection. Clin Infect Dis (2005) 1.13
Luminosity-independent measurement of the proton-proton total cross section at √s=8 TeV. Phys Rev Lett (2013) 1.13
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol (2000) 1.10
Direct observation of protein vibrations by selective incorporation of spectroscopically observable carbon-deuterium bonds in cytochrome c. J Am Chem Soc (2001) 1.09
Adhesion to and invasion of cultured human cells by Bartonella bacilliformis. Infect Immun (1992) 1.08
Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest (1991) 1.08
Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1994) 1.07
Selection for transport competence of C-terminal polypeptides derived from Escherichia coli hemolysin: the shortest peptide capable of autonomous HlyB/HlyD-dependent secretion comprises the C-terminal 62 amino acids of HlyA. Mol Gen Genet (1994) 1.06
Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood (1991) 1.05
A new core tetrasaccharide component from the lipopolysaccharide of Rhizobium trifolii ANU 843. J Biol Chem (1989) 1.05
Neuromesenchymal hamartoma of the small bowel. J Clin Gastroenterol (1990) 1.04
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies. Br J Haematol (1991) 1.03
Molecular epidemiology of Mycobacterium tuberculosis strains isolated during a 3-year period (1993 to 1995) in Seville, Spain. J Clin Microbiol (1997) 1.02
Recurrent embolism caused by floating thrombus in the thoracic aorta. Ann Vasc Surg (1998) 1.02
Kinetics of adherence of mucoid and non-mucoid Pseudomonas aeruginosa to plastic catheters. J Med Microbiol (1991) 1.01
Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest (1993) 1.01
Determination of plasma malondialdehyde-like material and its clinical application in stroke patients. J Clin Pathol (1980) 1.01
Characterization of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALM1, CALM2 and CALM3. Cell Calcium (1998) 1.00
MELODIE: a whole-farm model to study the dynamics of nutrients in dairy and pig farms with crops. Animal (2012) 1.00
Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. Eur Respir J (1997) 0.99
N-formimidoyl-thienamycin activity against anaerobes: effect of the inoculum, pH and culture media. J Antimicrob Chemother (1981) 0.99
Detection of Legionella pneumophila in wastewater by nested polymerase chain reaction. Res Microbiol (1997) 0.99
Selective adenosine release from human B but not T lymphoid cell line. J Biol Chem (1990) 0.99
Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella. Antimicrob Agents Chemother (1978) 0.98
Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells. Diagn Microbiol Infect Dis (1992) 0.98
Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1993) 0.97
Oral sex as a risk factor for Chlamydia-negative ureaplasma-negative nongonococcal urethritis. Sex Transm Dis (1988) 0.96
Comparison of broth microdilution and E-test for susceptibility testing of Neisseria meningitidis. J Clin Microbiol (1996) 0.96
In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria. Antimicrob Agents Chemother (1998) 0.96
Senile plaques in aged squirrel monkeys. Neurobiol Aging (1987) 0.96
Alteration of purine metabolism by AICA-riboside in human B lymphoblasts. Arch Biochem Biophys (1990) 0.95
Late onset Papillon-Lefèvre syndrome? A chromosomic, neutrophil function and microbiological study. J Clin Periodontol (1993) 0.95
Characterization of Candida parapsilosis complex isolates. Clin Microbiol Infect (2011) 0.94
Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli. J Bacteriol (1996) 0.94
Enzyme-mediated solvent extraction of carotenoids from marigold flower (Tagetes erecta). J Agric Food Chem (2002) 0.94
Value of serological diagnosis in congenital syphilis. Report of nine cases. Br J Vener Dis (1980) 0.94
Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction. J Clin Pathol (1983) 0.94
Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood (1994) 0.94
Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. J Antimicrob Chemother (2001) 0.93
Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. J Pharmacol Exp Ther (1999) 0.93
Gastrointestinal autonomic nerve tumors (plexosarcomas). is A radiological diagnosis possible? Eur Radiol (1998) 0.93